Innovation

Use of Dexatromethorphan; Sodium Benzoate, Phenylacetate and Phenylbuterate to Treat Autism Associated with Increased Levels of Glutamine and Glycine.

Vanderbilt University
posted on 10/31/2008

-


Innovation Details
 

This innovation is not currently available on the iBridge Network.

For more information, please contact:

lee.bridges@Vanderbilt.Edu

File Number: VU9944 


IP Protection

License Online

This innovation currently is not available for online licensing. Please contact the case manager at Vanderbilt University for more information.

request more info
People

No people are currently associated with this innovation.

[?]
Followed By

Follow this innovation



No one is following this innovation.

Organization
1849

Vanderbilt University


Profile
Related Tags

Find more innovations

February 11, 2009

4,076 members 12,312 innovations 109 organizations

Browse

Dr. Jörg Knäblein – Technology Scouting, Bayer Schering Pharma AG

"Through the iBridge Network, I was able to find a mouse model I was looking for. The collaboration available through the iBridge Network is crucial in driving innovation and I'll continue using it as a valued resource."  read more...